Morepen Labs has secured a ₹825 crore multi-year CDMO mandate from a global pharma major, with supplies set to begin in 4-5 months and execution running through Q1 FY27
Source :- Companies Read More
Morepen Labs wins ₹825 crore long-term CDMO deal with global drugmaker
- No Comments
- 6 Min Read
Share it :
Get free tips and resources right in your inbox, along with 10,000+ others
Categories
Latest Post
August 20, 2026
